220 related articles for article (PubMed ID: 17690594)
1. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
Altamura AC; Bobo WV; Meltzer HY
Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
Kasper S
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
[TBL] [Abstract][Full Text] [Related]
3. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
4. The evolving definition of treatment resistance.
Peuskens J
J Clin Psychiatry; 1999; 60 Suppl 12():4-8. PubMed ID: 10372602
[TBL] [Abstract][Full Text] [Related]
5. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
6. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
Burton S
J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
[TBL] [Abstract][Full Text] [Related]
7. Management strategies for the treatment of schizophrenia.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
[TBL] [Abstract][Full Text] [Related]
8. Evaluating clinical trial data: outcome measures.
Conley RR
J Clin Psychiatry; 2001; 62 Suppl 9():23-6; discussion 27-8. PubMed ID: 11379827
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of schizophrenia].
Houy-Durand E; Thibaut F
Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
[TBL] [Abstract][Full Text] [Related]
10. Insight and schizophrenia.
Buckley PF; Hasan S; Friedman L; Cerny C
Compr Psychiatry; 2001; 42(1):39-41. PubMed ID: 11154714
[TBL] [Abstract][Full Text] [Related]
11. Partial compliance in schizophrenia and the impact on patient outcomes.
Llorca PM
Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcomes in adolescents with schizophrenia.
Schulz SC; Findling RL; Friedman L; Kenny JT; Wise AL
J Clin Psychiatry; 1998; 59 Suppl 1():50-4; discussion 55-6. PubMed ID: 9448669
[TBL] [Abstract][Full Text] [Related]
13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
14. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
Harrow M; Jobe TH
J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
[TBL] [Abstract][Full Text] [Related]
15. [Schizophrenia and suicide--results of a control group comparison of schizophrenic inpatient suicides with schizophrenic inpatients without suicide].
Wolfersdorf M; Neher F;
Psychiatr Prax; 2003 Jul; 30(5):272-8. PubMed ID: 12872186
[TBL] [Abstract][Full Text] [Related]
16. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
17. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
Loas G; Azi A; Noisette C; Yon V
Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
[TBL] [Abstract][Full Text] [Related]
18. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
19. [Longterm treatment of schizophrenia].
Pajonk VF
MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
[TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]